South Korea · Information services startup
South Korea · Pillyze
Pillyze is a digital health and nutrition company based in South Korea.
Funding reportedLast round: Series A
About Pillyze
Pillyze is a digital health and nutrition company based in South Korea.
It specializes in personalized nutrition analysis, diet coaching, and food and supplement recommendations. The company offers an AI-powered app that assists users in managing their diet, blood sugar, exercise, and supplement intake, providing personalized insights based on research-backed information. Key services include Pillyze Plus, which features AI chat coaching and diet support, as well as tools for unlimited searches related to blood sugar insights and food predictions. Users can access detailed nutrition information for various foods, including calories and nutrient breakdowns, along with supplement recommendations and comparisons. Pillyze aims to support individuals seeking tailored guidance for healthier eating and lifestyle choices.
What company datasets say Pillyze raised
Funding, as reported
On a portfolio page
Investors who name them
Each firm lists Pillyze on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
pillyze inc.regulatory references in health industryproduct ratingsmarketinghealth productscustomer feedback percentagesenterprisesproduct reviewsseo servicesinformation technology & servicescontent marketingmetricsenterprise softwareai marketingproduct metricsmarketing automation
Built with from their website
Google Tag ManagerAmazon CloudFrontNAVERHandlebarsTailwind CSSGoogle WorkspaceBing Webmaster ToolsCloudFlareViewport MetaGoogle Drive
+8 more
Google Playdc.jswebpackFacebook SDKGoogle MeetPriority HintsReactGoogle Font API
- Sector
- Information services
- Region
- Seoul
- Full record
- Every detail in the company directory
Information services in South Korea
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Pillyze in front of investors. Or tell us what we have wrong.